Fundamental Data for ATSI

ATS MEDICA(NSDQ:ATSI)

ATS Medical Inc. manufactures and markets a mechanical bileaflet heart valve with a unique open pivot design. The company''s valve is used to treat heart valve failure caused by the natural aging process, rheumatic heart disease, prosthetic valve failure and congenital defects. The ATS heart valve is designed to advance the standard among mechanical heartvalves by incorporating a pivot consisting of protruding spheres upon which the leaflets of the valve pivot to open and close.

# Employees: 301

Address: 3905 Annapolis Lane North,Minneapolis,MN,USA

Phone: 763 553-7736

Fax: 763 557-2244

Website: www.atsmedical.com

Email: info@atsmedical.com

Sector: Medical

Industry: MED PRODUCTS

Executive Officers

Michael D. Dale (Chmn.; Presi.; C.E.O.; Dir.)

David R. Elizondo (V.P.; Research & Devlopt. & Gen. Mang.; Tissue Ope)

Jeremy J. Curtis (V.P.; Worldwide Mark.)

Michael R. Kramer (C.F.O.)

Theodore C. Skokos (Dir.,)

Dividend

Ex-Dividend Date: N/A

Annual Dividend: N/A

Current Dividend Yield: N/A

Dividend Paid (3 months): N/A

Indicated Dividend: N/A

Earnings

Last Earnings Date: 9/30/2009

Next Earnings Date(Expected): 2/22/2010

Mean EPS (Next Qtr): $0.00

Mean EPS (Year): ($0.04)

Mean Estimate(Long Term): $22.50

P/E Ratio(Based on EPS estimate): -0.010

Number of Estimates: 7

Shares Performance

Period	ATSI	Compare to S&P
YTD	2.52 %	-15.15 %
4 Weeks	9.62 %	8.43 %
12 Weeks	7.14 %	1.01 %

Shares Information

Analyst Coverage: Y

Avg Volume: 321090

Shares Outstanding: 71M

Market Cap: $0.21B

52 Week High: $3.50

52 Week Low: $2.05

P/E Ratio: -0.010

PEG Ratio: -0.010

Split: On 3/2/1990 ATSI split by factor of 3.000

Earnings Performance

EPS Growth in Last Quarter: -0.01 %

EPS Growth in Last Year: 83.33 %

Sales Growth in Last Quarter: -4.82 %

Sales Growth in Last Quarter: 17.35 %

Financials

Qtr Book Value: $2.77

Cash Flow/Share: ($0.01)

Change in Payout Ratio: -0.010

Price/Sales: 2.730